AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY.
主要な著者: | Ana Isabel Rodríguez Pérez, María A Pedrosa, Carmen M Labandeira, Rita Valenzuela, Aloia Quijano, Mariña Sanchez-Andrade, Juan Antonio Suárez-Quintanilla, Jose Lanciego, José Luis Labandeira-García |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Elsevier
2023-10-01
|
シリーズ: | IBRO Neuroscience Reports |
オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2667242123010126 |
類似資料
-
ANGIOTENSIN TYPE-1 RECEPTOR AND ACE2 AUTOANTIBODIES IN PARKINSON´S DISEASE
著者:: Ana Isabel Rodríguez Pérez, 等
出版事項: (2023-10-01) -
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
著者:: Carmen M. Labandeira, 等
出版事項: (2022-06-01) -
Angiotensin type-1 receptor autoantibodies promote alpha-synuclein aggregation in dopaminergic neurons
著者:: Lucia Lage, 等
出版事項: (2024-11-01) -
Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment
著者:: Jose L. Labandeira-Garcia, 等
出版事項: (2022-02-01) -
Brain renin-angiotensin system and dopaminergic cell vulnerability
著者:: Jose L Labandeira-Garcia, 等
出版事項: (2014-07-01)